German pharmaceutical company Boehringer Ingelheim is teaming up with IBM to leverage artificial intelligence (AI) in its drug discovery efforts. The partnership aims to harness IBM’s foundation model technology to accelerate the development of antibody therapeutics for various medical conditions. IBM’s AI technology in drug discovery Boehringer Ingelheim has joined the growing list of pharmaceutical ... Read more